PILOTforPulmonary: 2019 Fall Conference Coverage
Independent Conference Coverage from the 2019 Annual Meetings and Conferences. Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, IncPodcasts
The IPF Cell Atlas
Published: Nov. 13, 2019, 10:30 p.m.Duration: 5 minutes 53 seconds
Listed in: Science
Senescence, Senolytics, and IPF
Published: Nov. 13, 2019, 10:30 p.m.Duration: 4 minutes 23 seconds
Listed in: Science
The PRECISIONS Study
Published: Nov. 13, 2019, 10:30 p.m.Duration: 5 minutes 39 seconds
Listed in: Science
Genomics and Transcriptomics in PF
Published: Nov. 13, 2019, 10:30 p.m.Duration: 5 minutes 18 seconds
Listed in: Science
Importance of Pulmonary Fibrosis Patient Registries
Published: Nov. 13, 2019, 10:30 p.m.Duration: 3 minutes 20 seconds
Listed in: Science
Recent Developments in Methodologies to Support the Diagnosis of IPF
Published: Nov. 13, 2019, 10:30 p.m.Duration: 4 minutes 37 seconds
Listed in: Science
A New Study Evaluating Pulmonary Rehabilitation Added on to Antifibrotic Therapy
Published: Nov. 13, 2019, 10:30 p.m.Duration: 2 minutes 14 seconds
Listed in: Science
New Developments in Clinical Trials of Pulmonary Fibrosis
Published: Nov. 13, 2019, 10:30 p.m.Duration: 1 minute 38 seconds
Listed in: Science
Exploring Antifibrotic Therapy in Patients with Autoimmune-Associated Interstitial Lung Disease
Published: Nov. 13, 2019, 10:30 p.m.Duration: 3 minutes 12 seconds
Listed in: Science
Expanding the Use of Antifibrotic Therapy in Patients with PF
Published: Nov. 13, 2019, 10:30 p.m.Duration: 5 minutes 21 seconds
Listed in: Science
Considerations for the Management of Autoimmune-Related ILD and Chronic Hypersensitivity-Related ILD
Published: Nov. 13, 2019, 10:30 p.m.Duration: 2 minutes 53 seconds
Listed in: Science
Key Takeaways from Recent Pulmonary Conferences
Published: Nov. 13, 2019, 10:30 p.m.Duration: 5 minutes 12 seconds
Listed in: Science
Current Perspective on Antifibrotic Therapy for Patients with IPF
Published: Oct. 25, 2019, 8:32 p.m.Duration: 2 minutes 10 seconds
Listed in: Science
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases (The INBUILD Trial)
Published: Oct. 25, 2019, 8:32 p.m.Duration: 2 minutes 22 seconds
Listed in: Science
Goals of Care Across the Disease Continuum in IPF
Published: Oct. 25, 2019, 8:32 p.m.Duration: 3 minutes 13 seconds
Listed in: Science
Emerging Diagnostic Approaches to Patients with ILD
Published: Oct. 25, 2019, 8:32 p.m.Duration: 6 minutes 28 seconds
Listed in: Science
Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease
Published: Oct. 25, 2019, 8:32 p.m.Duration: 1 minute 58 seconds
Listed in: Science
Considerations for Geriatric ILD Patients
Published: Oct. 25, 2019, 8:32 p.m.Duration: 2 minutes 7 seconds
Listed in: Science
Nintedanib for Patients with Systemic Sclerosis-Related Interstitial Lung Disease
Published: Oct. 25, 2019, 8:32 p.m.Duration: 3 minutes 3 seconds
Listed in: Science
Inhaled NO in Patients at Risk for Pulmonary Hypertension Associated with Pulmonary Fibrosis
Published: Oct. 25, 2019, 8:32 p.m.Duration: 3 minutes 42 seconds
Listed in: Science
Clinical Pearls from New Orleans 2019
Published: Oct. 25, 2019, 8:32 p.m.Duration: 7 minutes 2 seconds
Listed in: Science